Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems

被引:13
|
作者
Potts, C. [1 ]
Richardson, J. [2 ]
Bond, R. B. [1 ]
Price, R. K. [3 ]
Mulvenna, M. D. [1 ]
Zvolsky, P. [2 ]
Harvey, M. [2 ]
Hughes, C. F. [3 ]
Duffy, F. [2 ]
机构
[1] Ulster Univ, Sch Comp Engn & Built Environm, Fac Comp, Coleraine, Londonderry, North Ireland
[2] Northern Hlth & Social Care Trust, Memory Serv, Belfast, Antrim, North Ireland
[3] Ulster Univ, Sch Biomed Sci, Fac Life & Hlth Sci, Coleraine, Londonderry, North Ireland
关键词
Cognitive screening test; Cognitive assessment; Alzheimer's disease; Vascular dementia; MCI; NHSCT Memory Service; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; CHINESE VERSION; VALIDATION; DIAGNOSIS; PERFORMANCE; BATTERY; RESERVE;
D O I
10.1007/s10433-021-00652-4
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
Diagnosing dementia can be challenging for clinicians, given the array of factors that contribute to changes in cognitive function. The Addenbrooke's Cognitive Examination III (ACE-III) is commonly used in dementia assessments, covering the domains of attention, memory, fluency, visuospatial and language. This study aims to (1) assess the reliability of ACE-III to differentiate between dementia, mild cognitive impairment (MCI) and controls and (2) establish whether the ACE-III is useful for diagnosing dementia subtypes. Client records from the Northern Health and Social Care Trust (NHSCT) Memory Service (n = 2,331, 2013-2019) were used in the analysis including people diagnosed with Alzheimer's disease (n = 637), vascular dementia (n = 252), mixed dementia (n = 490), MCI (n = 920) and controls (n = 32). There were significant differences in total ACE-III and subdomain scores between people with dementia, MCI and controls (p < 0.05 for all), with little overlap between distribution of total ACE-III scores (< 39%) between groups. The distribution of total ACE-III and subdomain scores across all dementias were similar. There were significant differences in scores for attention, memory and fluency between Alzheimer's disease and mixed dementia, and for visuospatial and language between Alzheimer's disease-vascular dementia (p < 0.05 for all). However, despite the significant differences across these subdomains, there was a high degree of overlap between these scores (> 73%) and thus the differences are not clinically relevant. The results suggest that ACE-III is a useful tool for discriminating between dementia, MCI and controls, but it is not reliable for discriminating between dementia subtypes. Nonetheless, the ACE-III is still a reliable tool for clinicians that can assist in making a dementia diagnosis in combination with other factors at assessment.
引用
收藏
页码:495 / 507
页数:13
相关论文
共 50 条
  • [1] Reliability of Addenbrooke's Cognitive Examination III in differentiating between dementia, mild cognitive impairment and older adults who have not reported cognitive problems
    C. Potts
    J. Richardson
    R. B. Bond
    R. K. Price
    M. D. Mulvenna
    P. Zvolsky
    M. Harvey
    C. F. Hughes
    F. Duffy
    European Journal of Ageing, 2022, 19 : 495 - 507
  • [2] Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia
    Peixoto, Bruno
    Machado, Milene
    Rocha, Patricia
    Macedo, Carla
    Machado, Antonio
    Baeta, Elia
    Goncalves, Gerly
    Pimentel, Paulo
    Lopes, Emanuela
    Monteiro, Luis
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 27 (06): : 781 - 786
  • [3] Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan
    Shintaro Takenoshita
    Seishi Terada
    Hidenori Yoshida
    Megumi Yamaguchi
    Mayumi Yabe
    Nao Imai
    Makiko Horiuchi
    Tomoko Miki
    Osamu Yokota
    Norihito Yamada
    BMC Geriatrics, 19
  • [4] Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan
    Takenoshita, Shintaro
    Terada, Seishi
    Yoshida, Hidenori
    Yamaguchi, Megumi
    Yabe, Mayumi
    Imai, Nao
    Horiuchi, Makiko
    Miki, Tomoko
    Yokota, Osamu
    Yamada, Norihito
    BMC GERIATRICS, 2019, 19 (1)
  • [5] Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia
    Kan, Kwai Ching
    Subramaniam, Ponnusamy
    Shahrizaila, Nortina
    Kamaruzzaman, Shahrul Bahyah
    Razali, Rosdinom
    Ghazali, Shazli Ezzat
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2019, 9 (01): : 66 - 76
  • [6] Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia
    Li, Xiaojia
    Yang, Lili
    Yin, Jia
    Yu, Nengwei
    Ye, Fang
    JOURNAL OF CLINICAL NEUROLOGY, 2019, 15 (03): : 313 - 320
  • [7] Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease
    Sousa, Nariana Mattos Figueiredo
    Brucki, Sonia Maria Dozzi
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2023, 81 (02) : 155 - 163
  • [8] Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment
    Beishon, Lucy C.
    Batterham, Angus P.
    Quinn, Terry J.
    Nelson, Christopher P.
    Panerai, Ronney B.
    Robinson, Thompson
    Haunton, Victoria J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (12):
  • [9] Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests
    Matias-Guiu, Jordi A.
    Cortes-Martinez, Ana
    Valles-Salgado, Maria
    Rognoni, Teresa
    Fernandez-Matarrubia, Marta
    Moreno-Ramos, Teresa
    Matias-Guiu, Jorge
    INTERNATIONAL PSYCHOGERIATRICS, 2017, 29 (01) : 105 - 113
  • [10] Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment
    Pan, Feng-Feng
    Wang, Ying
    Huang, Lin
    Huang, Yue
    Guo, Qi-Hao
    AGING & MENTAL HEALTH, 2022, 26 (02) : 384 - 391